Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.23 USD | -1.60% | -3.91% | +5.13% |
05-13 | HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating | MT |
05-09 | Transcript : Clearside Biomedical, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Sales 2024 * | 562K 769K | Sales 2025 * | 7.36M 10.06M | Capitalization | 91.92M 126M |
---|---|---|---|---|---|
Net income 2024 * | -41M -56.08M | Net income 2025 * | -42M -57.45M | EV / Sales 2024 * | 126 x |
Net cash position 2024 * | 21.26M 29.08M | Net Debt 2025 * | 12.33M 16.86M | EV / Sales 2025 * | 14.2 x |
P/E ratio 2024 * |
-2.18
x | P/E ratio 2025 * |
-2.13
x | Employees | 30 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.54% |
Latest transcript on Clearside Biomedical, Inc.
1 day | -1.60% | ||
1 week | -3.91% | ||
Current month | -2.38% | ||
1 month | -1.60% | ||
3 months | -5.38% | ||
6 months | +26.80% | ||
Current year | +5.13% |
Managers | Title | Age | Since |
---|---|---|---|
George Lasezkay
CEO | Chief Executive Officer | 72 | 17-08-07 |
Charles Deignan
DFI | Director of Finance/CFO | 59 | 11-12-31 |
Susan L. Coultas
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Lasezkay
CEO | Chief Executive Officer | 72 | 17-08-07 |
Jeffrey Edwards
BRD | Director/Board Member | 64 | 18-09-25 |
Christy Shaffer
BRD | Director/Board Member | 66 | 11-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 1.23 | -1.60% | 110,213 |
24-05-10 | 1.25 | -7.41% | 286,328 |
24-05-09 | 1.35 | +6.30% | 136,371 |
24-05-08 | 1.27 | -0.78% | 162,224 |
24-05-07 | 1.28 | 0.00% | 197,243 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.13% | 91.92M | |
+5.66% | 111B | |
+11.23% | 105B | |
-2.21% | 21.93B | |
-12.15% | 22.34B | |
-5.57% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- CLSD Stock